Loading BDCC…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("BDCC","financials")Full statements spill as a table. For one cell: =jivedata("BDCC","Revenue") or =jivedata("BDCC","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
BDCC • CIK 0001495648
| (in thousands, except per share data) | FY 2021 | FY 2022 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenues | $0 | $0 | $0 | $0 |
| Gain (Loss) on Sale of Financing Receivable | — | — | $0 | $0 |
| Other Nonoperating Income (Expense) | — | — | $-43.718 | $-49.041 |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $-15.779 | $-5.007 | $-2,938.168 | $-2,106.78 |
| Income Tax Expense (Benefit) | $0 | — | $0 | $0 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | — | $-2,938.168 | $-2,106.78 |
| General and Administrative Expense | $0 | $0.788 | $145.378 | $92.355 |
| Professional Fees | $0 | $76.395 | $2,749.072 | $1,251.959 |
| Operating Expenses | $0 | $77.183 | $2,894.45 | $1,344.314 |
| Operating Income (Loss) | $0 | $-77.183 | $-2,894.45 | $-1,344.314 |
| Interest Expense | $17.034 | $11.576 | $44.67 | $50.088 |
| Gain (Loss) on Derivative Instruments, Net, Pretax | — | $-0.047 | $0 | $0 |
| Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | — | — | $0.952 | $1.047 |
| (in thousands, except per share data) | FY 2021 | FY 2022 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | $0 | — | $1.881 | $1.609 |
| Assets, Current | $0 | $0.317 | $1.881 | $0.001 |
| Accounts Payable and Other Accrued Liabilities | — | — | $248.875 | $276.187 |
| Notes Payable | $6.5 | $52.5 | $500.485 | $520.465 |
| Liabilities, Current | $475.084 | $377.886 | $868.332 | $949.9 |
| Common Stock, Value, Issued | $0.986 | $0.986 | $0.379 | $0.379 |
| Additional Paid in Capital | $1,917.776 | $2,020.298 | $9,654.093 | $9,667.233 |
| Retained Earnings (Accumulated Deficit) | $-2,393.846 | $-2,398.853 | $-12,170.982 | $-12,267.57 |
| Stockholders' Equity Attributable to Parent | $-475.084 | $-377.569 | $-866.451 | $-949.899 |
| Common Stock, Shares Authorized | 1,000,000,000 | 1,000,000,000 | 500,000,000 | 500,000,000 |
| Common Stock, Shares, Issued | 9,863,000 | 9,863,000 | 37,996,794 | 37,997,373 |
| (in thousands, except per share data) | FY 2021 | FY 2022 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | — | $-2,938.168 | $-2,106.78 |
| Unrealized Gain (Loss) on Derivatives | — | — | $0 | $0 |
| Share-based Payment Arrangement, Noncash Expense | — | — | $2,464.141 | $1,075.347 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | $0 | $0.317 | $1.881 | $-0.15 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | $0.317 | $1.881 | $1.999 |
| Increase (Decrease) in Accounts Payable and Accrued Liabilities | $-0.794 | $0.981 | $111.112 | $118.182 |
| Net Cash Provided by (Used in) Operating Activities | $0 | $-77.183 | $-336.708 | $-160.479 |
| Net Cash Provided by (Used in) Investing Activities | $0 | $0 | $0 | $0 |
| Proceeds from Notes Payable | — | $52.5 | $181.617 | $73.599 |
| Proceeds from Issuance of Common Stock | — | — | $78 | $20 |
| Net Cash Provided by (Used in) Financing Activities | $0 | $77.5 | $338.589 | $160.329 |